{"entity":{"type":"insider","cik":"0001843847","url":"/insider/0001843847","json_url":"/insider/0001843847.json","name":"Vivo Panda, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":3,"first":"2021-02-09","last":"2023-11-22","span_basis":"filed_date"},"name_variants":[{"name":"Vivo Panda, LLC","source":"filing","n_filings":3,"first_seen":"2021-02-09","last_seen":"2023-11-22"}],"transactions":[{"id":8024134,"accession":"0001213900-23-089692","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-23-089692","line_url":"/filing/0001213900-23-089692#line-3","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda Fund, L.P.; Vivo Capital Fund VIII, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Capital VIII, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1707.0,"shares_display":"1,707","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":1536.3,"total_display":"1,536.30","shares_owned_after":1952302.0,"shares_owned_after_display":"1,952,302","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider"},{"id":8024132,"accession":"0001213900-23-089692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-089692","line_url":"/filing/0001213900-23-089692#line-2","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda Fund, L.P.; Vivo Capital Fund VIII, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Capital VIII, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1457.0,"shares_display":"1,457","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":1311.3,"total_display":"1,311.30","shares_owned_after":111662.0,"shares_owned_after_display":"111,662","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider"},{"id":8024130,"accession":"0001213900-23-089692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-089692","line_url":"/filing/0001213900-23-089692#line-1","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda Fund, L.P.; Vivo Capital Fund VIII, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Capital VIII, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":236.0,"shares_display":"236","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":212.4,"total_display":"212.40","shares_owned_after":269587.0,"shares_owned_after_display":"269,587","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider"},{"id":8727901,"accession":"0001213900-23-088909","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909#line-9","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27465.0,"shares_display":"27,465","price_per_share":0.92,"price_display":"0.92","price_state":"stated","total_value":25267.8,"total_display":"25,267.80","shares_owned_after":1954009.0,"shares_owned_after_display":"1,954,009","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-20","scope":"insider"},{"id":8727898,"accession":"0001213900-23-088909","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909#line-8","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23443.0,"shares_display":"23,443","price_per_share":0.92,"price_display":"0.92","price_state":"stated","total_value":21567.56,"total_display":"21,567.56","shares_owned_after":113119.0,"shares_owned_after_display":"113,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-20","scope":"insider"},{"id":8727895,"accession":"0001213900-23-088909","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909#line-7","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3792.0,"shares_display":"3,792","price_per_share":0.92,"price_display":"0.92","price_state":"stated","total_value":3488.64,"total_display":"3,488.64","shares_owned_after":269823.0,"shares_owned_after_display":"269,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-20","scope":"insider"},{"id":8727892,"accession":"0001213900-23-088909","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909#line-6","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Comon Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8211.0,"shares_display":"8,211","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":7636.23,"total_display":"7,636.23","shares_owned_after":1981474.0,"shares_owned_after_display":"1,981,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider"},{"id":8727889,"accession":"0001213900-23-088909","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909#line-5","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7009.0,"shares_display":"7,009","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":6518.37,"total_display":"6,518.37","shares_owned_after":136562.0,"shares_owned_after_display":"136,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider"},{"id":8727887,"accession":"0001213900-23-088909","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909#line-4","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1134.0,"shares_display":"1,134","price_per_share":0.93,"price_display":"0.93","price_state":"stated","total_value":1054.62,"total_display":"1,054.62","shares_owned_after":273615.0,"shares_owned_after_display":"273,615","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider"},{"id":8727886,"accession":"0001213900-23-088909","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909#line-3","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7531.0,"shares_display":"7,531","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":7229.76,"total_display":"7,229.76","shares_owned_after":1989685.0,"shares_owned_after_display":"1,989,685","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":8727881,"accession":"0001213900-23-088909","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909#line-2","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6429.0,"shares_display":"6,429","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":6171.84,"total_display":"6,171.84","shares_owned_after":143571.0,"shares_owned_after_display":"143,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":8727877,"accession":"0001213900-23-088909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-088909","line_url":"/filing/0001213900-23-088909#line-1","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Capital Surplus Fund VIII, L.P.; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.; Vivo Panda, LLC; Vivo Opportunity, LLC; Vivo Panda Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1040.0,"shares_display":"1,040","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":998.4,"total_display":"998.40","shares_owned_after":274749.0,"shares_owned_after_display":"274,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":4924723,"accession":"0001209191-21-008758","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-21-008758","line_url":"/filing/0001209191-21-008758#line-14","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda, LLC; Vivo Opportunity Fund, L.P.; Vivo Panda Fund, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity, LLC; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144.0,"shares_display":"144","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":2880.0,"total_display":"2,880.00","shares_owned_after":1821483.0,"shares_owned_after_display":"1,821,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":4924719,"accession":"0001209191-21-008758","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-21-008758","line_url":"/filing/0001209191-21-008758#line-13","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda, LLC; Vivo Opportunity Fund, L.P.; Vivo Panda Fund, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity, LLC; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62.0,"shares_display":"62","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":1240.0,"total_display":"1,240.00","shares_owned_after":1448286.0,"shares_owned_after_display":"1,448,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":4924716,"accession":"0001209191-21-008758","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-21-008758","line_url":"/filing/0001209191-21-008758#line-12","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda, LLC; Vivo Opportunity Fund, L.P.; Vivo Panda Fund, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity, LLC; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20.0,"shares_display":"20","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":400.0,"total_display":"400.00","shares_owned_after":251522.0,"shares_owned_after_display":"251,522","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":4924713,"accession":"0001209191-21-008758","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-21-008758","line_url":"/filing/0001209191-21-008758#line-11","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda, LLC; Vivo Opportunity Fund, L.P.; Vivo Panda Fund, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity, LLC; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175733.0,"shares_display":"175,733","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":3514660.0,"total_display":"3,514,660.00","shares_owned_after":1997216.0,"shares_owned_after_display":"1,997,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":4924709,"accession":"0001209191-21-008758","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-21-008758","line_url":"/filing/0001209191-21-008758#line-10","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda, LLC; Vivo Opportunity Fund, L.P.; Vivo Panda Fund, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity, LLC; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":150000.0,"shares_owned_after_display":"150,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":4924706,"accession":"0001209191-21-008758","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-21-008758","line_url":"/filing/0001209191-21-008758#line-9","is_derivative":false,"issuer_cik":"0001618788","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001618788","owner_cik":null,"owner_name":"Vivo Panda, LLC; Vivo Opportunity Fund, L.P.; Vivo Panda Fund, L.P.; Vivo Capital Surplus Fund VIII, L.P.; Vivo Opportunity, LLC; Vivo Capital VIII, LLC; Vivo Capital Fund VIII, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24267.0,"shares_display":"24,267","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":485340.0,"total_display":"485,340.00","shares_owned_after":275789.0,"shares_owned_after_display":"275,789","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001641281","name":"Bolt Biotherapeutics, Inc.","url":"/issuer/0001641281","role":"Ten percent owner","n_filings":3,"first_seen":"2021-02-09","last_seen":"2023-11-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001843847","retrieved_at":"2026-08-21T09:57:41+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}